Vaxcyte, Inc. (PCVX)
48.41
-0.03
(-0.06%)
USD |
NASDAQ |
May 19, 14:48
Vaxcyte Shareholders Equity (Quarterly) : 2.996B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 456.23M |
| Cytokinetics, Inc. | -826.57M |
| CareDx, Inc. | 313.54M |
| Syndax Pharmaceuticals, Inc. | 41.62M |
| Cogent Biosciences, Inc. | 607.69M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.348B |
| Total Liabilities (Quarterly) | 352.29M |
| Debt to Equity Ratio | 0.0388 |
| Current Ratio | 7.491 |
| Net Debt Paydown Yield | -0.11% |